Amgen Research Offers Clue to Weight-Loss Drug Paradox
Product·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Amgen Inc. researchers have found a clue to one of the more puzzling questions in obesity drug development: How can blocking a hormone help people lose weight when activating the same hormone appears to work, too?
This research sheds light on the complexities of obesity treatment and may influence future drug development strategies.
Amgen
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Amgen Inc. researchers have found a clue to one of the more puzzling questions in obesity drug development: How can blocking a hormone help people lose weight when activating the same hormone appears to work, too?”
Bloomberg — Amgen Research Offers Clue to Weight-Loss Drug Paradox